Plus Therapeutics Inc. buy BiotechBee
Start price
10.10.22
/
50%
€8.85
Target price
31.12.24
€15.00
Performance (%)
-46.85%
End price
21.12.22
€4.70
Summary
This prediction ended on 21.12.22 with a price of €4.70. The BUY prediction by BiotechBee for Plus Therapeutics Inc. performed very badly with a performance of -46.85%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Plus Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 1.432% | 2.628% | 12.457% | 60.347% |
| iShares Nasdaq 100 | 1.892% | -0.458% | 1.248% | 85.806% |
| iShares Nikkei 225® | -1.619% | 11.097% | 27.382% | 64.398% |
| iShares S&P 500 | 1.921% | 1.159% | 1.635% | 59.419% |
According to BiotechBee what are the pros and cons of Plus Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year